Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1993
OBJECTIVES: I. Assess the efficacy and toxicity of mexiletine in the management of paresthesias and pain in patients with diabetic neuropathy.
Epistemonikos ID: 863a96c163b497888dcc61af073a887b47a30147
First added on: May 03, 2024